| Ident. | Authors (with country if any) | Title |
|---|
| 000011 (2020) |
Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France] | Type 1 interferons as a potential treatment against COVID-19 |
| 000018 (2020) |
B. Coutard [France] ; C. Valle [France] ; X. De Lamballerie [France] ; B. Canard [France] ; N. G. Seidah [Canada] ; E. Decroly [France] | The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade |
| 000103 (2020) |
Ka-Tim Choy [République populaire de Chine] ; Alvina Yin-Lam Wong [République populaire de Chine] ; Prathanporn Kaewpreedee [République populaire de Chine] ; Sin Fun Sia [République populaire de Chine] ; Dongdong Chen [République populaire de Chine] ; Kenrie Pui Yan Hui [République populaire de Chine] ; Daniel Ka Wing Chu [République populaire de Chine] ; Michael Chi Wai Chan [République populaire de Chine] ; Peter Pak-Hang Cheung [République populaire de Chine] ; Xuhui Huang [République populaire de Chine] ; Malik Peiris [République populaire de Chine] ; Hui-Ling Yen [République populaire de Chine] | Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro |
| 000105 (2020) |
Ashleigh Shannon [France] ; Nhung Thi Tuyet Le [France] ; Barbara Selisko [France] ; Cecilia Eydoux [France] ; Karine Alvarez [France] ; Jean-Claude Guillemot [France] ; Etienne Decroly [France] ; Olve Peersen [États-Unis, France] ; Francois Ferron [France] ; Bruno Canard [France] | Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites |
| 000408 (2020) |
Christian Ja Sigrist ; Alan Bridge ; Philippe Le Mercier | A potential role for integrins in host cell entry by SARS-CoV-2 |
| 000484 (2019) |
Ariane J. Brown [États-Unis] ; John J. Won [États-Unis] ; Rachel L. Graham [États-Unis] ; Kenneth H. Dinnon [États-Unis] ; Amy C. Sims [États-Unis] ; Joy Y. Feng [États-Unis] ; Tomas Cihlar [États-Unis] ; Mark R. Denison [États-Unis] ; Ralph S. Baric [États-Unis] ; Timothy P. Sheahan [États-Unis] | Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase |
| 000493 (2019) |
John H. Beigel [États-Unis] ; Hannah H. Nam [États-Unis] ; Peter L. Adams [États-Unis] ; Amy Krafft [États-Unis] ; William L. Ince [États-Unis] ; Samer S. El-Kamary [États-Unis] ; Amy C. Sims [États-Unis] | Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference |
| 000498 (2019) |
Christian Brechot [États-Unis] ; Juliet Bryant [France] ; Hubert Endtz [Pays-Bas] ; Robert F. Garry [États-Unis] ; Diane E. Griffin [États-Unis] ; Sharon R. Lewin [Australie] ; Natalia Mercer [États-Unis] ; Albert Osterhaus [Allemagne] ; Valentina Picot [France] ; Anders Vahlne [États-Unis, Suède] ; Georges M. G. M. Verjans [Pays-Bas, Allemagne] ; Scott Weaver [États-Unis] | 2018 international meeting of the Global Virus Network |
| 000510 (2018) |
Massinissa Si Mehand [Suisse] ; Farah Al-Shorbaji [Suisse] ; Piers Millett [Royaume-Uni] ; Bernadette Murgue [Suisse] | The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts |
| 000528 (2018) |
Hsu-Feng Chu [Taïwan] ; Chiao-Che Chen [Taïwan] ; David C. Moses [Taïwan] ; Yau-Hung Chen [Taïwan] ; Chao-Hsiung Lin [Taïwan] ; Ying-Chieh Tsai [Taïwan] ; Chi-Yuan Chou [Taïwan] | Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine |
| 000574 (2017) |
Wahiba Aouadi [France] ; Cécilia Eydoux [France] ; Bruno Coutard [France] ; Baptiste Martin [France] ; Françoise Debart [France] ; Jean Jacques Vasseur [France] ; Jean Marie Contreras [France] ; Christophe Morice [France] ; Gilles Quérat [France] ; Marie-Louise Jung [France] ; Bruno Canard [France] ; Jean-Claude Guillemot [France] ; Etienne Decroly [France] | Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay |
| 000575 (2017) |
Thiagarajan Venkataraman ; Matthew B. Frieman | The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis |
| 000594 (2017) |
Jennifer L. Mckimm-Breschkin | Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference |
| 000668 (2016) |
William J. Liu [République populaire de Chine] ; Min Zhao [République populaire de Chine] ; Kefang Liu [République populaire de Chine] ; Kun Xu [République populaire de Chine] ; Gary Wong [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] ; George F. Gao [République populaire de Chine] | T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV |
| 000681 (2016) |
Yohichi Kumaki [États-Unis] ; Andres M. Salazar [États-Unis] ; Miles K. Wandersee [États-Unis] ; Dale L. Barnard [États-Unis] | Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model |
| 000826 (2015) |
Neeltje Van Doremalen ; Vincent J. Munster | Animal models of Middle East respiratory syndrome coronavirus infection |
| 000842 (2014) |
Yahira M. Báez-Santos ; Sarah E. St. John ; Andrew D. Mesecar | The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds |
| 000926 (2014) |
Ding Xiang Liu [Singapour] ; To Sing Fung [Singapour] ; Kelvin Kian-Long Chong [Singapour] ; Aditi Shukla [Allemagne] ; Rolf Hilgenfeld [Allemagne] | Accessory proteins of SARS-CoV and other coronaviruses |
| 000948 (2013) |
Luca Zinzula ; Enzo Tramontano | Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: Hide, mask, hit |
| 000956 (2013) |
Fang Li | Receptor recognition and cross-species infections of SARS coronavirus |
| 000981 (2013) |
Rolf Hilgenfeld [Allemagne] ; Malik Peiris [République populaire de Chine] | From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses |
